𝔖 Bobbio Scriptorium

✦ LIBER ✦

Long-Term Intravesical Adjuvant Chemotherapy Further Reduces Recurrence Rate Compared with Short-Term Intravesical Chemotherapy and Short-Term Therapy with Bacillus Calmette-Guérin (BCG) in Patients with Non–Muscle-Invasive Bladder Carcinoma

✍ Scribed by Martin G. Friedrich; Uwe Pichlmeier; Hartwig Schwaibold; Stefan Conrad; Hartwig Huland

Book ID: 113609939
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 227 KB
Volume: 52
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2007.02.063

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Editorial Comment on: Long-Term Intraves

Editorial Comment on: Long-Term Intravesical Adjuvant Chemotherapy Further Reduces Recurrence Rate Compared with Short-Term Intravesical Chemotherapy and Short-Term Therapy with Bacillus Calmette-Guérin (BCG) in Patients with Non–Muscle-Invasive Bladder Cancer

✍ Christopher P. Evans 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Long-Term Efficacy Results of EORTC Geni

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Richard J. Sylvester; Maurizio A. Brausi; Wim J. Kirkels; Wolfgang Hoeltl; Ferna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Re: Long-Term Efficacy Results of EORTC

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Donald L. Lamm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Re: Long-Term Efficacy Results of EORTC

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin Plus Isoniazid in Patients With Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Wood, David P. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

Re: Richard J. Sylvester, Maurizio A. Br

Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766–73

✍ Tommaso Cai; Lorenzo Giuseppe Luciani; Gianni Malossini 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Reply to Tomasso Cai, Lorenzo Giuseppe L

Reply to Tomasso Cai, Lorenzo Giuseppe Luciani and Gianni Malossini's Letter to the Editor re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766–73

✍ Richard J. Sylvester; Maurizio A. Brausi; Ziya Kirkali; Theo M. de Reijke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB